The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125300081 12530008 1 I 20111025 20160706 20160706 EXP US-CIPLA LTD.-2011US00155 CIPLA ZAKARIA S, LU KY, NUSSENBLATT V, BROWNER I. ATRIAL FLUTTER ASSOCIATED WITH CARBOPLATIN ADMINISTRATION. THE ANNALS OF PHARMACOTHERAPY. 2011;45:E59 0.00 Y 0.00000 20160706 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125300081 12530008 1 PS CARBOPLATIN. CARBOPLATIN 1 Unknown 370 MG, ON DAY 1, BASED ON AUC 5 U U 77383 370 MG INFUSION
125300081 12530008 2 SS ETOPOSIDE. ETOPOSIDE 1 Unknown 150 MG, ON DAYS 1-3 BASED ON A BODY SURFACE AREA U U 0 150 MG INFUSION
125300081 12530008 3 SS Ondansetron ONDANSETRON 1 Unknown 8 MG, BID U U 0 8 MG
125300081 12530008 4 SS Ondansetron ONDANSETRON 1 Intravenous (not otherwise specified) 24 MG, UNK U U 0 24 MG
125300081 12530008 5 SS RANITIDINE. RANITIDINE 1 Unknown 50 MG, UNK U U 0 50 MG
125300081 12530008 6 SS DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 Unknown 25 MG, UNK U U 0 25 MG
125300081 12530008 7 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown 12 MG, UNK U U 0 12 MG
125300081 12530008 8 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MG, UNK U U 0 300 MG
125300081 12530008 9 C Pantoprazole PANTOPRAZOLE SODIUM 1 Unknown 40 MG, DAILY U U 0 40 MG
125300081 12530008 10 C Ipratropium IPRATROPIUM 1 Unknown UNK, TID, NEBULIZED THERAPY U U 0
125300081 12530008 11 C Oxycodone OXYCODONE 1 Unknown 5 MG, PRN U U 0 5 MG
125300081 12530008 12 C ASPIRIN. ASPIRIN 1 Unknown 81 MG, DAILY U U 0 81 MG
125300081 12530008 13 C Docusate DOCUSATE 1 Unknown 100 MG, DAILY U U 0 100 MG
125300081 12530008 14 C METOPROLOL. METOPROLOL 1 Unknown 12.5 MG, BID U U 0 12.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125300081 12530008 1 Small cell lung cancer extensive stage
125300081 12530008 2 Small cell lung cancer extensive stage

Outcome of event

Event ID CASEID OUTC COD
125300081 12530008 HO
125300081 12530008 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125300081 12530008 Atrial flutter
125300081 12530008 Death

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found